ZSCAN20

Across TCGA pan-cancer cohorts, ZSCAN20 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZSCAN20 data layer compared with 28 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ZSCAN20 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated ZSCAN20 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

HNSC, CCRCC, and LUAD are the cancer types where ZSCAN20 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.121	1.000	.017	17	view →
CCRCC	DFS	Tertile	All	0.812	0.272	.006	14	view →
LUAD	DFS	Median	All	0.662	1.000	.022	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ZSCAN20–HNSC (OS)

Open the HNSC breakdown →